Clinical Trials Administrator Archives – December 1, 2007
December 1, 2007
View Archives Issues
-
Drug safety has become an integral part of CT research from start to finish
Pharmaceutical companies and clinical research institutions have adhered to drug safety regulations and standards for decades. But in recent years there has been a trend of increasing attention paid to pharmacovigilance, with drug safety staffs increasing rapidly at research institutions and clinical research organizations (CROs). -
Here are examples of best practices in drug safety
Clinical trial sites and research institutions could save time and improve reporting efficiency by working with a drug safety group, experts say. -
Q&A: Sponsor's perspective on site selection and patient recruitment
CTA: The biopharmaceutical industry is increasingly challenged to meet patient recruitment goals. Given your experience in this area, would you please describe what data-driven patient recruitment means and how your company employs it? -
One-stop shop web site provides CR sites with tools, templates
Clinical research sites in the process of revising tools or forms might find a new web site, funded by the National Institutes of Health (NIH) a useful place to begin the process. -
CR changes result in more trial site work and challenges
Clinical trial sites and CT coordinators increasingly feel pressure to fit more work into an already long day.